New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks

MedicalXpress | 六月 24, 2026

A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine.